Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation

被引:30
作者
Depreter, Barbara [1 ]
Devreese, Katrien M. J. [1 ]
机构
[1] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, Coagulat Lab, Pintelaan 185 2P8, B-9000 Ghent, Belgium
关键词
anticoagulant drugs; clotting time; lupus anticoagulant; mixing test; Rosner index; POSITIVE LABORATORY DIAGNOSIS; CIRCULATING ANTICOAGULANT; GUIDELINES; COMMENCEMENT; RIVAROXABAN; PLASMAS; ASSAY;
D O I
10.1515/cclm-2015-0978
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Lupus anticoagulant (LAC) testing includes a screening, mixing and confirmation step. Although recently published guidelines on LAC testing are a useful step towards standardization, a lack of consensus remains whether to express mixing tests in clotting time (CT) or index of circulating anticoagulant (ICA). The influence of anticoagulant therapy, e.g. vitamin K antagonists (VKA) or direct oral anticoagulants (DOAC) on both methods of interpretation remains to be investigated. The objective of this study was to contribute to a simplification and standardization of the LAC three-step interpretation on the level of the mixing test. Methods: Samples from 148 consecutive patients with LAC request and prolonged screening step, and 77 samples from patients non-suspicious for LAC treated with VKA (n = 37) or DOAC (n = 30) were retrospectively evaluated. An activated partial thromboplastin time (aPTT) and dilute Russell's viper venom time (dRVVT) were used for routine LAC testing. The supplemental anticoagulant samples were tested with dRVVT only. We focused on the interpretation differences for mixing tests expressed as CT or ICA and compared the final LAC conclusion within each distinct group of concordant and discordant mixing test results. Results: Mixing test interpretation by CT resulted in 10 (dRVVT) and 16 (aPTT) more LAC positive patients compared to interpretation with ICA. Isolated prolonged dRVVT screen mix ICA results were exclusively observed in samples from VKA-treated patients without suspicion for LAC. Conclusions: We recommend using CT in respect to the 99th percentile cut-off for interpretation of mixing steps in order to reach the highest sensitivity and specificity in LAC detection.
引用
收藏
页码:1511 / 1516
页数:6
相关论文
共 25 条
[1]   False negative or false positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: reply to a rebuttal [J].
Aboud, M. ;
Morel-Kopp, M. -C. ;
Ward, C. ;
Coyle, L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (07) :1436-1437
[2]   False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant [J].
Aboud, M. ;
Morel-Kopp, M. -C. ;
Ward, C. ;
Coyle, L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (09) :2070-2073
[3]  
[Anonymous], H60A CLSI
[4]   Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome [J].
Arachchillage, D. R. J. ;
Mackie, I. J. ;
Efthymiou, M. ;
Isenberg, D. A. ;
Machin, S. J. ;
Cohen, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (07) :1264-1273
[5]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[6]   Lupus anticoagulant testing and anticoagulation do not mix: quantitation of discrepant results and potential approaches to reduce false positives [J].
Chandler, Jocelyn B. ;
Torres, Richard ;
Rinder, Henry M. ;
Tormey, Christopher A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (05) :704-707
[7]  
Chang SH, 2002, AM J CLIN PATHOL, V117, P62
[8]   Lupus Anticoagulant Testing Performance and Practices by North American Clinical Laboratories [J].
Dembitzer, Francine R. ;
Kraemer, Marlies R. Ledford ;
Meijer, Piet ;
Peerschke, Ellinor I. B. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (05) :764-773
[9]   Mixing studies in lupus anticoagulant testing are required at least in some type of samples [J].
Devreese, K. M. J. ;
De Laat, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (08) :1475-1478
[10]   No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants? [J].
Devreese, K. M. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) :1120-1122